“…For example, central administration of galanin increases food and ethanol consumption (Leibowitz et al, 2003), and galanin-OE mice display an increased intake of dietary fat and ethanol (Karatayev et al, 2009). Indeed, the actions of central and peripheral galanin and its receptors in the regulation of metabolism, obesity, and appetite, including galanin receptor-linked mechanisms in experimental obesity, were recently reviewed in detail (Fang et al, 2012a), with the authors recommending development of GAL 1 antagonism as a novel antiobesity strategy. However, in early clinical studies, there was no strong association reported between GAL or GAL 1 genetic variants and obesity or dietary fat intake in obese children and adolescents (Schauble et al, 2005) and no evidence for a GAL 2 linkage to obesity (Sutton et al, 2006) (Table 6).…”